Idorsia Management
Management criteria checks 4/4
Idorsia's CEO is Jean-Paul Clozel, appointed in Jan 2017, has a tenure of 7.25 years. total yearly compensation is CHF2.73M, comprised of 27.5% salary and 72.5% bonuses, including company stock and options. directly owns 20.03% of the company’s shares, worth $68.32M. The average tenure of the management team and the board of directors is 6.8 years and 3.9 years respectively.
Key information
Jean-Paul Clozel
Chief executive officer
CHF2.7m
Total compensation
| CEO salary percentage | 27.5% |
| CEO tenure | 7.3yrs |
| CEO ownership | 20.0% |
| Management average tenure | 6.8yrs |
| Board average tenure | 3.9yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -CHF374m |
| Jun 30 2023 | n/a | n/a | -CHF814m |
| Mar 31 2023 | n/a | n/a | -CHF843m |
| Dec 31 2022 | CHF3m | CHF750k | -CHF828m |
| Sep 30 2022 | n/a | n/a | -CHF887m |
| Jun 30 2022 | n/a | n/a | -CHF810m |
| Mar 31 2022 | n/a | n/a | -CHF728m |
| Dec 31 2021 | CHF3m | CHF750k | -CHF635m |
| Sep 30 2021 | n/a | n/a | -CHF520m |
| Jun 30 2021 | n/a | n/a | -CHF499m |
| Mar 31 2021 | n/a | n/a | -CHF429m |
| Dec 31 2020 | CHF3m | CHF750k | -CHF445m |
Compensation vs Market: Jean-Paul's total compensation ($USD2.98M) is about average for companies of similar size in the US market ($USD2.37M).
Compensation vs Earnings: Jean-Paul's compensation has been consistent with company performance over the past year.
CEO
Jean-Paul Clozel (68 yo)
7.3yrs
Tenure
CHF2,725,271
Compensation
Mr. Jean-Paul Clozel, M.D., co- founded Actelion Ltd (alternate name Actelion AG ) in 1997 and has been its Chief Executive Officer since 1999. He is Executive Director at Idorsia Ltd. Mr. Clozel serves as...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 7.3yrs | CHF2.73m | 20.03% CHF 68.3m | |
| Executive VP & CFO | 7.3yrs | no data | 0.053% CHF 180.6k | |
| Executive VP & Chief Scientific Officer | 7.3yrs | no data | 7.14% CHF 24.4m | |
| Senior VP and Head of Investor Relations & Corporate Communications | 6.8yrs | no data | no data | |
| Senior VP | 1.4yrs | no data | no data | |
| Senior VP & Head of Global Human Resources | 6.8yrs | no data | no data | |
| Executive VP & Chief Medical Officer | no data | no data | 0.11% CHF 371.8k | |
| Senior VP & Head of Technical Operations | no data | no data | no data | |
| Senior VP & Head of Drug Discovery Biology | no data | no data | no data | |
| Senior VP & Head of Drug Discovery Chemistry | no data | no data | no data | |
| Executive VP & Head of Global Clinical Development | 5.2yrs | no data | 0.0027% CHF 9.0k |
6.8yrs
Average Tenure
60yo
Average Age
Experienced Management: IDRS.F's management team is seasoned and experienced (6.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | no data | CHF2.73m | 20.03% CHF 68.3m | |
| Non-Executive Director | 2.9yrs | CHF148.88k | 0.0061% CHF 20.9k | |
| Non-Executive Director | 3.9yrs | CHF158.04k | 0.0082% CHF 27.8k | |
| Non-Executive Director | 3.9yrs | CHF176.73k | 0.039% CHF 134.5k | |
| Non-Executive Chairman | 4.9yrs | CHF347.12k | 0.037% CHF 124.8k | |
| Non-Executive Director | less than a year | no data | no data | |
| Non-Executive Director | 3.9yrs | CHF168.61k | 0.015% CHF 49.5k | |
| Non-Executive Director | 2.9yrs | CHF164.24k | 0.011% CHF 35.8k |
3.9yrs
Average Tenure
65yo
Average Age
Experienced Board: IDRS.F's board of directors are considered experienced (3.9 years average tenure).